Pierre Lozeron

3.9k total citations
65 papers, 1.2k citations indexed

About

Pierre Lozeron is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pierre Lozeron has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 20 papers in Molecular Biology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pierre Lozeron's work include Peripheral Neuropathies and Disorders (23 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers) and Hereditary Neurological Disorders (14 papers). Pierre Lozeron is often cited by papers focused on Peripheral Neuropathies and Disorders (23 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers) and Hereditary Neurological Disorders (14 papers). Pierre Lozeron collaborates with scholars based in France, United States and Switzerland. Pierre Lozeron's co-authors include Catherine Lacroix, David Adams, Christian Denier, Marie Théaudin, David R. Adams, B. Ducot, Zoïa Mincheva, C. Lacroix, Nathalie Kubis and Clovis Adam and has published in prestigious journals such as Neurology, Annals of Neurology and Scientific Reports.

In The Last Decade

Pierre Lozeron

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Lozeron France 20 582 455 198 180 176 65 1.2k
Yuichi Kawagashira Japan 23 665 1.1× 887 1.9× 480 2.4× 319 1.8× 206 1.2× 62 1.7k
Xavier Ayrignac France 22 343 0.6× 814 1.8× 251 1.3× 222 1.2× 63 0.4× 95 1.7k
Yeşim Parman Türkiye 23 580 1.0× 637 1.4× 482 2.4× 107 0.6× 205 1.2× 98 1.6k
Andrea Cortese Italy 19 572 1.0× 433 1.0× 615 3.1× 93 0.5× 66 0.4× 66 1.3k
J. Franques France 21 256 0.4× 533 1.2× 242 1.2× 88 0.5× 89 0.5× 44 927
Jean‐Philippe Camdessanché France 25 300 0.5× 1.5k 3.2× 463 2.3× 173 1.0× 97 0.6× 101 2.0k
Boleslaw H. Liwnicz United States 24 388 0.7× 456 1.0× 214 1.1× 219 1.2× 74 0.4× 57 1.6k
Byoung Joon Kim South Korea 23 283 0.5× 806 1.8× 171 0.9× 112 0.6× 51 0.3× 114 1.6k
B. Eymard France 29 1.5k 2.6× 478 1.1× 439 2.2× 206 1.1× 245 1.4× 82 2.6k
S. Tokiguchi Japan 19 546 0.9× 568 1.2× 310 1.6× 248 1.4× 34 0.2× 50 1.5k

Countries citing papers authored by Pierre Lozeron

Since Specialization
Citations

This map shows the geographic impact of Pierre Lozeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Lozeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Lozeron more than expected).

Fields of papers citing papers by Pierre Lozeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Lozeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Lozeron. The network helps show where Pierre Lozeron may publish in the future.

Co-authorship network of co-authors of Pierre Lozeron

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Lozeron. A scholar is included among the top collaborators of Pierre Lozeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Lozeron. Pierre Lozeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubis, Nathalie, et al.. (2024). EEG and acute confusional state at the emergency department. Neurophysiologie Clinique. 54(4). 102966–102966. 2 indexed citations
2.
Legriel, Stéphane, Nicolas Deye, Bruno Mégarbane, et al.. (2023). Predicting neurological outcome after cardiac arrest by combining computational parameters extracted from standard and deviant responses from auditory evoked potentials. Frontiers in Neuroscience. 17. 988394–988394.
4.
Meppiel, Elodie, et al.. (2021). Contribution of intermittent photic stimulation to routine EEG. Neurophysiologie Clinique. 51(6). 549–553. 2 indexed citations
5.
Roos, Caroline, et al.. (2021). Spectral analysis of EEG in etiological assessment of patients with transient neurological deficits. Neurophysiologie Clinique. 51(3). 225–232. 5 indexed citations
6.
Poujois, Aurélia, et al.. (2020). Associated co-morbidities in a retrospective cohort of orthostatic tremor. Journal of Neurology. 268(2). 467–473. 1 indexed citations
7.
Théaudin, Marie, Pierre Lozeron, Vincent Algalarrondo, et al.. (2018). Upper limb onset of hereditary transthyretin amyloidosis is common in non‐endemic areas. European Journal of Neurology. 26(3). 497–497. 20 indexed citations
8.
Lozeron, Pierre, Elodie Meppiel, Caroline Roos, et al.. (2017). Contribution of EEG in transient neurological deficits. Journal of Neurology. 265(1). 89–97. 5 indexed citations
9.
Lozeron, Pierre, Aurélia Poujois, Elodie Meppiel, et al.. (2017). Inhibitory rTMS applied on somatosensory cortex in Wilson’s disease patients with hand dystonia. Journal of Neural Transmission. 124(10). 1161–1170. 9 indexed citations
10.
Lozeron, Pierre, et al.. (2016). Contribution of TMS and rTMS in the Understanding of the Pathophysiology and in the Treatment of Dystonia. Frontiers in Neural Circuits. 10. 90–90. 28 indexed citations
11.
Lozeron, Pierre & Nathalie Kubis. (2015). Prise en charge de la douleur neuropathique. La Revue de Médecine Interne. 36(7). 480–486. 2 indexed citations
12.
Lozeron, Pierre. (2014). Neuropathies atypiques du diabète. Revue Neurologique. 170(12). 837–842. 2 indexed citations
13.
Adams, David, Pierre Lozeron, & Vincent Algalarrondo. (2014). Utilisation de l’ARN interférence dans le traitement de l’amylose héréditaire due à une mutation de la transthyrétine. médecine/sciences. 30(4). 345–347. 1 indexed citations
14.
Antonini, Térésa, Pierre Lozeron, C. Lacroix, et al.. (2013). Reversibility of Acquired Amyloid Polyneuropathy After Liver Retransplantation. American Journal of Transplantation. 13(10). 2734–2738. 16 indexed citations
15.
Lozeron, Pierre, Jean‐Marc Trocello, & Nathalie Kubis. (2013). Acquired neuropathies. Journal of Neurology. 260(9). 2433–2440. 4 indexed citations
16.
Adams, David, Pierre Lozeron, & Catherine Lacroix. (2012). Amyloid neuropathies. Current Opinion in Neurology. 25(5). 564–572. 70 indexed citations
17.
Sah, Dinah W.Y., Qingmin Chen, Anthony Rossomando, et al.. (2011). ALN-TTR, an RNAI therapeutic for the treatment of transthyretin amyloidosis. Nucleic Acid Therapeutics. 21(5). 1 indexed citations
18.
Lozeron, Pierre & David Adams. (2011). Advances in the treatment of chronic inflammatory demyelinating neuropathies in 2010. Journal of Neurology. 258(9). 1737–1741. 4 indexed citations
19.
Denier, Christian, G. Tertian, Vincent Ribrag, et al.. (2008). Multifocal deficits due to leukemic meningoradiculitis in chronic lymphocytic leukemia. Journal of the Neurological Sciences. 277(1-2). 130–132. 10 indexed citations
20.
Lozeron, Pierre, et al.. (2003). MRI of peripheral nerve lesions of the lower limbs. Neuroradiology. 45(3). 166–170. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026